Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease

Journal of Clinical Neuroscience

Volumn 20, Issue 3, 2013, Pages 357-361

  Liang, Furu ^a   Jia, Jianping ^a   Wang, Shuying ^a   Qin, Wei ^a   Liu, Guorong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BAOTOU CENTRAL HOSPITAL   (China)

Author keywords

Alzheimer's disease; Biomarker; Dementia; Soluble form of the receptor for advanced glycation end products (sRAGE); Soluble low density lipoprotein receptor related protein 1 (sLRP)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E GENE; ARTICLE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEURODEGENERATIVE DEMENTIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AREA UNDER CURVE; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84875212826     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.06.005     Document Type: Article

References (32)

1. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180
2. R.E. Tanzi, R.D. Moir, and S.L. Wagner Clearance of Alzheimer's Abeta peptide: the many roads to perdition Neuron 43 2004 605 608
3. M. Shibata, S. Yamada, and S.R. Kumar Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J Clin Invest 106 2000 1489 1499
4. R. Deane, and B.V. Zlokovic Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease Curr Alzheimer Res 4 2007 191 197
5. A. Sagare, R. Deane, and R.D. Bell Clearance of amyloid-β by circulating lipoprotein receptors Nat Med 13 2007 1029 1031
6. K.A. Quinn, P.G. Grimsley, and Y.P. Dai Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma J Biol Chem 272 1997 23946 23951
7. R. Deane, S. Du Yan, and R.K. Submamaryan RAGE mediates amyloid-beta transport across the blood-brain barrier and accumulation in brain Nat Med 9 2003 907 913
8. B.V. Zlokovic The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 57 2008 178 201
9. O. Arancio, H.P. Zhang, and X. Chen RAGE potentiates Abeta induced perturbation of neuronal function in transgenic mice EMBO J 23 2004 4096 4105
10. R. Deane, Z.H. Wu, and B.V. Zlokovic RAGE (yin) Versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier Stroke 35 Suppl I 2004 2628 2631
11. A. Raucci, S. Cugusi, and A. Antonelli A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a distintegrin and metalloprotease 10 (ADAM10) FASEB J 22 2008 3716 3727
12. E. Emanuele, A. D'Angelo, and C. Tomaino Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia Arch Neurol 62 2005 1734 1736
13. M.C. Tierney, R.H. Fisher, and A.J. Lewis The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases Neurology 38 1988 359 364
14. G.C. Roman, T.K. Tatemichi, and T. Erkinjuntti Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
15. I.G. McKeith, D.W. Dickson, and J. Lowe Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 2005 1863 1872
16. B. Dubois, D. Burn, and C. Goetz Diagnostic procedures for Parkinson's Disease Dementia: Recommendations from the movement disorder society task force Movement Disord 22 2007 2314 2324
17. D. Neary, J.S. Snowden, and L. Gustafson Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554
18. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
19. A. Gaultier, S. Arandjelovic, and X. Li A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents J Clin Invest 118 2008 161 172
20. C. Falcone, E. Emanuele, and A. D'Angelo Plasma levels of soluble receptor for advanced glycation end production and coronary artery disease in nondiabetic men Arterioscler Thromb Vasc Biol 25 2005 1032 1037
21. P.R. Wenham, W.H. Price, and G. Blundell Apolipoprotein E genotyping by one-stage PCR Lancet 337 1991 1158 1159
22. P. Armitage, and G. Berry Statistical methods in medical research second ed. 1987 Blackwell Scientific Publications Boston (MA) Oxford, England p. 387-393
23. J.C. Lambert, F. Wavrant-De Vriéze, and P. Amouyel Association at LRP gene locus with sporadic late-onset Alzheimer's disease Lancet 351 1998 1787 1788
24. G.W. Rebeck, S.D. Harr, and D.K. Strickland Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein Ann Neurol. 37 1995 211 217
25. J.A. Cam, and G. Bu Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family Mol Neurodegener 1 2006 8
26. M. Shibata, S. Yamada, and S.R. Kumar Clearance of Alzheimer's amyloid-beta 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J Clin Invest. 106 2000 1489 1499
27. D.E. Kang, C.U. Pietrzik, and L. Baum Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway J Clin Invest. 106 2000 1159 1166
28. Q. Liu Zhang J, Tran H, et al. LRP1 shedding in human brain, roles of ADAM10 and ADAM17 Mol Neurodegener. 4 2009 17
29. R. Ramasamy, S.J. Vannucci, and S.S. Yan Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology 15 2005 16R 28R
30. J. Iłzecka Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis Acta Neurol Scand 120 2009 119 122
31. C. De Palma, S. Falcone, and C. Panzeri Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection J Neurochem 106 2008 193 204
32. T. Erkinjuntti Diagnosis and management of vascular cognitive impairment and dementia J Neural Transm Suppl 63 2002 91 109